| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/24/2000 | EP1002092A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| 05/24/2000 | EP1002091A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 05/24/2000 | EP1002090A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES |
| 05/24/2000 | EP1002084A1 Mammalian cytokine: interleukin-b30 and related reagents |
| 05/24/2000 | EP1002083A1 Aprotinin variants with improved properties and bikunins of aprotinin variants |
| 05/24/2000 | EP1002081A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 05/24/2000 | EP1002080A1 Fluorescent proteins as cell-type specific reporter |
| 05/24/2000 | EP1002079A2 Novel inhibitor of cellular proliferation |
| 05/24/2000 | EP1002077A1 Secreted proteins encoded by human chromosome 13 |
| 05/24/2000 | EP1002076A1 Proteins mediating switch recombination |
| 05/24/2000 | EP1002075A1 Adipocyte-specific protein homologs |
| 05/24/2000 | EP1002074A1 Calcium-binding phosphoprotein |
| 05/24/2000 | EP1002073A2 Cell activation process and reagents therefor |
| 05/24/2000 | EP1002072A1 Human semaphorin e and polynucleotides encoding it |
| 05/24/2000 | EP1002071A1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 05/24/2000 | EP1002069A1 Peptides containing the motif igd and their use as cell migration modulators |
| 05/24/2000 | EP1002068A1 Mutations in the myostatin gene cause double-muscling in mammals |
| 05/24/2000 | EP1002067A1 Strong early seed-specific gene regulatory region |
| 05/24/2000 | EP1002066A1 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 05/24/2000 | EP1002063A1 Cloning and characterization of a human adenylyl cyclase |
| 05/24/2000 | EP1002058A1 Isolation and identification of novel polymerases |
| 05/24/2000 | EP1002054A1 Process for the production of virus in cell cultures |
| 05/24/2000 | EP1001984A1 NOVEL ESTROGEN RECEPTOR $g(b) AND ISOFORMS |
| 05/24/2000 | EP1001983A1 NOVEL ESTROGEN $g(b) RECEPTOR AND ISOFORMS |
| 05/24/2000 | EP1001982A1 Cardiotrophin-like cytokine |
| 05/24/2000 | EP1001980A1 Recombinant expression of insulin c-peptide |
| 05/24/2000 | EP1001978A1 Angiotensin derivatives |
| 05/24/2000 | EP1001965A1 Tissue plasminogen activator-like protease |
| 05/24/2000 | EP1001964A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 05/24/2000 | EP1001963A1 Nucleic acid ladders |
| 05/24/2000 | EP1001815A1 Vectors derived from antibodies for transferring substances into cells |
| 05/24/2000 | EP1001807A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases |
| 05/24/2000 | EP1001806A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 05/24/2000 | EP1001795A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 05/24/2000 | EP1001758A1 Use of a drug capable of modulating the regulation of upc-2 and method for screening for potential drugs against obesity |
| 05/24/2000 | EP1001675A1 Platelet suspensions and methods for resuspending platelets |
| 05/24/2000 | CN1254379A Methods of production of amidated peptide through use of fusion protein |
| 05/24/2000 | CN1254377A Mammalian CHKL effector cell-cycle checkpoint protein kinase materials and methods |
| 05/24/2000 | CN1254376A 端粒酶逆转录酶 Telomerase reverse transcriptase |
| 05/24/2000 | CN1254374A Inhibitors of cellulolytic, xylanolytic and 'beta'-glucanolytic enzymes |
| 05/24/2000 | CN1254294A Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof |
| 05/24/2000 | CN1254277A Method for propagation of hair |
| 05/24/2000 | CN1052733C Immuno-stimulatory monoclonal antibodies |
| 05/23/2000 | USRE36713 APC gene and nucleic acid probes derived therefrom |
| 05/23/2000 | US6066783 Genes encoding insecticidal proteins |
| 05/23/2000 | US6066782 Nucleotide sequences coding branching enzyme and a disproportionation enzyme; for the production of adjusted starches in amylogenic plants |
| 05/23/2000 | US6066618 Regulation of cell proliferation and differentiation using peptides |
| 05/23/2000 | US6066617 Polypeptide |
| 05/23/2000 | US6066502 Endothelin converting enzyme (ECE) |
| 05/23/2000 | US6066498 Compositions for the treatment and diagnosis of immune disorders |
| 05/23/2000 | US6066496 Apparatus for culturing mammalian respiratory epithelial |
| 05/23/2000 | US6066495 Methods and apparatus for the conditioning of ligament replacement tissue |
| 05/23/2000 | US6066478 Dna encoding a hybrid protein including a recombinase able to recognize a recombination sequence and a linking region recognized by a ligand; for complementation cells used to produce viral vectors used in gene therapy |
| 05/23/2000 | US6066476 Modified green fluorescent proteins |
| 05/23/2000 | US6066475 Parathyroid cytosolic autoantigens recognized by autoantibodies from patients with acquired hypoparathyroidism |
| 05/23/2000 | US6066472 Nucleotide sequences isolated from glioblastoma cdna library; for probes, primers, antisense agents, drug screening, anticarcinogenic agents |
| 05/23/2000 | US6066356 Genetic engineering; animal feeds; foods |
| 05/23/2000 | US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions |
| 05/23/2000 | US6066317 Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells |
| 05/23/2000 | CA2165162C Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 05/23/2000 | CA2062732C A mutated subtilisin protease |
| 05/18/2000 | WO2000028066A1 Host cells expressing recombinant human erythropoietin |
| 05/18/2000 | WO2000028065A1 Method for the production of fvii |
| 05/18/2000 | WO2000028062A1 Novel system for regulating transgene expression |
| 05/18/2000 | WO2000028061A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 05/18/2000 | WO2000028060A2 Cells for the production of helper dependent adenoviral vectors |
| 05/18/2000 | WO2000028058A2 Transcriptional activator lec1 nucleic acids, polypeptides and their uses |
| 05/18/2000 | WO2000028055A2 Hypersensitive response elicitor-induced stress resistance |
| 05/18/2000 | WO2000028052A2 Nucleic acid molecules from rice encoding an r1 protein and their use for the production of modified starch |
| 05/18/2000 | WO2000028047A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
| 05/18/2000 | WO2000028046A1 Coffea arabica mannanase |
| 05/18/2000 | WO2000028045A2 Human hydrolase proteins |
| 05/18/2000 | WO2000028043A2 Polypeptides having lactonohydrolase activity and nucleic acids encoding same |
| 05/18/2000 | WO2000028041A1 Delivery of superoxide dismutase to neuronal cells |
| 05/18/2000 | WO2000028039A2 Identification of senv genotypes |
| 05/18/2000 | WO2000028038A2 Virulence genes and proteins, and their use |
| 05/18/2000 | WO2000028035A1 CHEMOKINE β-7 |
| 05/18/2000 | WO2000028034A2 Cytokine signal regulators |
| 05/18/2000 | WO2000028029A2 Cell surface glycoproteins |
| 05/18/2000 | WO2000028027A2 Corticosteroid synthesis-associated genes |
| 05/18/2000 | WO2000028025A1 Pholasin |
| 05/18/2000 | WO2000028024A1 htfIIIA HUMAN GENE AND CODED hTFIIIA PROTEIN |
| 05/18/2000 | WO2000028022A1 Pge synthase and methods and means for modulating its activity |
| 05/18/2000 | WO2000028020A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 05/18/2000 | WO2000028016A1 T cells specific for target antigens and methods and vaccines based thereon |
| 05/18/2000 | WO2000028011A2 Fk506-based regulation of biological events |
| 05/18/2000 | WO2000028010A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 05/18/2000 | WO2000028008A1 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase |
| 05/18/2000 | WO2000028005A1 Nucleic acids encoding taxus geranylgeranyl diphosphate synthase, and methods of use |
| 05/18/2000 | WO2000028004A1 Virus vectors and methods of making and administering the same |
| 05/18/2000 | WO2000028002A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey |
| 05/18/2000 | WO2000028001A1 Modified exosomes and uses |
| 05/18/2000 | WO2000028000A2 Method for producing dendritic cells |
| 05/18/2000 | WO2000027999A2 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 05/18/2000 | WO2000027998A2 Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 05/18/2000 | WO2000027997A1 Method for the massive culture of cells producing recombinant human erythropoietin |
| 05/18/2000 | WO2000027996A1 Serum free medium for chondrocyte-like cells |
| 05/18/2000 | WO2000027995A1 Embryonic stem cells |
| 05/18/2000 | WO2000027994A2 Chlamydia pneumoniae genome sequence |
| 05/18/2000 | WO2000027884A1 Antibodies, mini-antibodies or antibody fragments binding to vitamin e and the use thereof |